Table 3.

Subgroup Analysis for Symptomatic Intracranial Hemorrhage

Subgroup	No. of studies	No. of participants	Pooled rate (95% CI)	P value of subgroup testing
Median National Institutes of Health Stroke Scale score
>10	8	1250	3% (2%–4%)	0.46
≤10	6	2327	4% (3%–4%)
Idarucizumab
Yes	8	405	3% (1%–7%)	0.54
No	6	3150	4% (3%–4%)